2026 LCRF | AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer

The overarching theme of the proposals should be centered around understanding the biology of SCLC and developing strategies toward improving outcomes for patients with SCLC.

LCRF encourageד applications on a wide variety of topics related to SCLC, including but not limited to the following:

• Advanced Screening and Diagnostic Technologies

• Disease Progression and Acquired Resistance

• Biomarkers and Immuno-Oncology

• Biospecimen-based research

▪ Longitudinal studies of SCLC progression from limited-stage to extensive-stage disease

▪ Investigation of tumor and microenvironmental changes before, during, and after treatment to understand the evolution of resistance

Funding: $500,000
Duration: 3 years

Research Authority deadline: 8.7.26

LOI (required) due date: 15.7.26

Full proposal due date: 5.10.26